查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2028 年的流感疫苗市场预测——COVID-19 的影响以及按疫苗类型、病毒类型、技术、给药途径和目标群体进行的全球分析
市场调查报告书
商品编码
1153721

到 2028 年的流感疫苗市场预测——COVID-19 的影响以及按疫苗类型、病毒类型、技术、给药途径和目标群体进行的全球分析

Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type, Virus Type, Technology, Route of Administration, and Target Group
出版日期: | 出版商: The Insight Partners | 英文 209 Pages | 订单完成后即时交付

价格

流感疫苗市场预计将从 2021 年的 747853 万美元增长到 2028 年的 1227249 万美元。预计从 2022 年到 2028 年，复合年增长率将达到 7.4%。政府加大对促进流感疫苗接种的支持以及市场领先公司和政府加大投资是推动市场的主要因素。

州政府支持促进疫苗接种计划的努力。例如，澳大利亚政府通过其国家免疫计划 (NIP) 向面临流感相关并发症风险的人群免费分发季节性流感疫苗。到 2022 年，将有足够的疫苗覆盖所有有资格通过 NIP 获得政府资助的流感疫苗的风险人群。

以下是一些支持政府支持流感疫苗接种的例子。

2022 年 7 月，公共服务和采购部长 Filomena Tassi 和卫生部长 Jean-Yves Duclos 宣布，加拿大政府将与GlaxoSmithCry (GSK) 签署一份新合同，以支持可持续的流感大流行准备工作。加拿大政府维持大流行性流感疫苗储备，以防流感大流行。

2022 年 7 月，卫生部长 Audrey Gordon 和长期护理部长 Scott Johnston 宣布，高剂量流感疫苗将扩大到所有 65 岁及以上的成年人，以帮助保护更多曼尼托巴居民免受流感侵害。

维多利亚州政府已收到一项拨款和报销计划，以在 2022 年 6 月和 2022 年 7 月之前改善全科医生和药房对流感疫苗的获取和使用。

2022 年 6 月，新西兰政府从 2022 年 7 月 1 日起将免费流感疫苗的使用范围扩大到另外 800,000 名新西兰人。现在可以为 3 至 12 岁的儿童以及有严重心理健康和成瘾问题的人免费接种流感疫苗。

台湾疾病预防控制中心（台湾CDC）和卫生福利部举行了题为“让我们一起保持健康”的媒体活动，启动了 2021 年政府资助的流感疫苗接种计划。活动现场，周局长、谭大使、蒋新率先接种流感疫苗，并呼吁符合政府资助流感疫苗接种条件的人员在项目结束后儘快接种流感疫苗。

2019 年 9 月，美国总统唐纳德特朗普签署了一项行政命令，促进开发更好的疫苗，以防止季节性和潜在的大流行性流感爆发。

2021 年 10 月，随着流感季节的临近，州政府敦促所有纽芬兰人和拉布拉多人接种流感疫苗。从 2021 年 10 月 25 日起，地方卫生局 (RHA) 开始提供免费的流感疫苗接种诊所。此外，人们可以通过家庭医生或当地药房接种疫苗。因此，越来越多的政府支持在全球范围内推广流感疫苗接种，推动了流感疫苗市场的发展。

疫苗类型见解

根据疫苗类型，流感疫苗市场分为四价和三价疫苗。预计四价疫苗部分将在 2022 年占据更大的市场份额。该细分市场预计在预测期内将实现高复合年增长率。四价流感疫苗可预防四种流感病毒，包括两种甲型流感病毒和两种乙型流感病毒。美国 2021-2022 季的所有流感疫苗均为四价疫苗。不同的疫苗被批准用于不同的年龄组。

病毒类型洞察

根据病毒类型，流感疫苗市场分为甲型流感病毒和乙型流感病毒。预计该细分市场在预测期内将实现更快的复合年增长率。A 型流感病毒的市场增长是由于它是最常见的流感形式，可以感染动物，儘管与这种流感相关的疾病更为常见。

技术见解

基于技术，流感疫苗市场分为蛋基和细胞基。到 2022 年，以鸡蛋为基础的细分市场预计将占据更大的市场份额。预计该细分市场在预测期内将实现更快的复合年增长率。以鸡蛋为基础的细分市场的市场增长归功于通过使用了 70 多年的以鸡蛋为基础的製造工艺来製造流感疫苗的最常见方法。

给药途径洞察力

根据给药途径，流感疫苗市场分为註射剂和鼻腔喷雾剂。注射剂预计将在 2022 年占据更大的市场份额。预计该细分市场在预测期内将实现更高的复合年增长率。可注射部分的市场增长归因于它是最常见的流感疫苗接种方法。

目标群体见解

全球流感疫苗市场按目标群体分为婴儿、儿童、成人和老年人。到 2021 年，婴儿细分市场将占据更大的市场份额。然而，在预测期内，老年人（老年人）部分预计将以最高增长率增长。

报告中引用了国际贸易管理局 (ITA)、Farmindustria-Bain & Company、EFPIA 成员协会、世界卫生组织 (WHO)、国际商业监测 (BMI)、急诊医学部、Indian Journal of Medical Sciences等流感疫苗市场。是一些主要和次要信息

目录

第 1 章 简介

  • 调查范围
  • Insight Partners 研究报告指南
  • 市场细分
    • 全球流感疫苗市场，按疫苗类型
    • 按病毒类型划分的全球流感疫苗市场
    • 全球流感疫苗市场，按技术分类
    • 全球流感疫苗市场:按给药途径分类
    • 全球流感疫苗市场:按目标组
    • 全球流感疫苗市场，按地区

第二章流感疫苗市场——要点

第三章研究方法论

  • 调查对象
  • 二次调查
  • 初步调查

第四章流感疫苗市场——市场格局

  • PEST分析
    • 北美 PEST 分析
    • 欧洲 PEST 分析
    • 亚太 PEST 分析
    • 中东和非洲 PEST 分析
    • 拉丁美洲 PEST 分析
  • 专家意见

5 全球流感疫苗市场——主要市场动态

  • 市场驱动力
    • 加大政府对推广流感疫苗的支持力度
    • 顶级公司和政府增加投资
  • 市场製约因素
    • 疫苗研发成本高
  • 市场机会
    • 新兴市场的发展
  • 未来趋势
    • 强大的流感疫苗候选管道
  • 影响分析

第六章流感疫苗市场——全球分析

  • 全球流感疫苗市场:收入和预测与分析
  • 全球流感疫苗市场:按地区预测和分析
  • 全球流感疫苗市场:区域市场潜力分析
  • 公司分析
    • 主要参与者的市场定位
    • 公司比较分析
  • 增长战略分析
  • 主要参与者的表现
    • Sanofi
    • Sekiras

第 7 章流感疫苗市场分析和预测到 2028 年（按疫苗类型）

  • 全球流感疫苗市场:2022-2028 (%) by Vaccine Type
  • 四价疫苗
  • 三价疫苗

第 8 章流感疫苗市场分析和预测到 2028 年（按病毒类型）

  • 全球流感疫苗市场:2022 年和 2028 年 (%) 按病毒类型
  • A型流感病毒
  • B型流感病毒

到 2028 年的第 9 章流感疫苗市场分析和预测（按技术）

  • 2022 年和 2028 年按技术分列的全球流感疫苗市场 (%)
  • 鸡蛋为主
  • 基于细胞的

第 10 章流感疫苗市场分析及到 2028 年的预测（按给药途径）

  • 全球流感疫苗市场:2022 年和 2028 年（%）按给药途径
  • 注射
  • 喷鼻剂

第 11 章流感疫苗市场分析和预测到 2028 年（按目标组）

  • 全球流感疫苗市场:2022-2028 年按目标组划分（%）
  • 婴儿
  • 孩子
  • 成人
  • 老年人

第 12 章流感疫苗市场分析和预测到 2028 年（区域分析）

    • 北美
      • 美国
      • 加拿大
      • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
      • 日本
      • 中国
      • 韩国
      • 澳大利亚
      • 亚太其他地区
    • 中东/非洲
      • 沙特阿拉伯
      • 阿联酋
      • 南非
      • 其他中东
    • 拉丁美洲
      • 巴西
      • 阿根廷
      • 其他拉丁美洲地区

第 13 章 COVID-19 大流行对全球流感疫苗市场的影响

  • 北美
  • 欧洲
  • 亚太地区
  • 中东和非洲
  • 拉丁美洲

第 14 章流感疫苗市场:行业格局

  • 2021-2028 年流感疫苗市场增长战略
  • 无机增长战略
  • 有机增长战略

第十五章公司简介

  • Moderna, Inc.
  • SEQIRUS
  • Sanofi
  • GlaxoSmithKline plc.
  • Hualan Biological Engineering Inc.
  • Emergent BioSolutions Inc.
  • Mitsubishi Chemical Group Corporation
  • Serum Institute of India Pvt. Ltd
  • MYLAN N.V.
  • AstraZeneca

第十六章 附录

  • 关于洞察合作伙伴
  • 词彙表
Product Code: TIPRE00004070

The influenza vaccines market is expected to grow from US$ 7,478.53 million in 2021 to US$ 12,272.49 million by 2028. It is expected to grow with a CAGR of 7.4% from 2022 to 2028. Increasing government support to promote influenza vaccination and rising investment by top market players and governments are the major factors boosting the market.

The governments of various states are supporting the promotional activities of vaccination program. For instance, the Australian government gives a free seasonal influenza vaccine to those at risk of influenza-related complications through the National Immunization Program (NIP). By 2022, enough vaccines have been given to cover all risk groups eligible for a government-funded flu vaccine through the NIP.

Below are a few more instances supporting the government support for influenza vaccination:

In July 2022, Public Services and Procurement Minister Filomena Tassi and Health Minister Jean-Yves Duclos announced that the Government of Canada had signed a new contract with GlaxoSmithKline (GSK) to support a sustainable influenza pandemic readiness. The Government of Canada maintains pandemic influenza vaccine preparedness in the event of an influenza pandemic.

In July 2022, Health Minister Audrey Gordon and Long-term Care Minister Scott Johnston announced that the Manitoba government would expand the high-dose flu vaccine eligibility to include all adults aged 65 and over to ensure more Manitoba people are protected against influenza.

The Victorian government received a grant and reimbursement program to help GPs and pharmacies improve access and uptake of the influenza vaccines by June and July 2022.

In June 2022, The New Zealand government expanded the access to free flu vaccines, with an additional 800,000 New Zealanders eligible from July 1, 2022. Children aged 3 to 12 years and people with severe mental health or addiction problems can now get a free dose of the flu vaccines.

Taiwan's Centers for Disease Control (Taiwan CDC), and the Ministry of Health and Welfare, organized a media event, titled "Let's Stay Healthy Together" to kick off the 2021 government-funded influenza vaccination program. At the event, Director General Chou, Ambassador Tan, and Hsin Chiang were the first to be vaccinated to encourage eligible people to receive government-funded flu vaccines to get their flu vaccinations as soon as possible following the program.

In September 2019, US President Donald Trump signed an executive order to promote the development of better vaccines to protect against seasonal flu and the potential for pandemic flu outbreaks.

In Oct 2021, with flu season approaching, the Provincial Government was encouraging all Newfoundlanders and Labradorians to get a flu shot in the year 2021. Starting October 25, 2021, the Regional Health Authorities (RHAs) have begun hosting free flu vaccination clinics. People can also get the vaccine through their family doctor or local pharmacy. Thus, increasing government support to promote influenza vaccination worldwide is driving the influenza vaccines market.

Vaccine Type Insights

Based on the vaccine type, the influenza vaccines market is segmented into quadrivalent vaccines and trivalent vaccines. The quadrivalent vaccines segment is likely to hold a larger market share in 2022. The same segment is anticipated to register a higher CAGR during the forecast period. The quadrivalent influenza (flu) vaccine protects against 4 influenza viruses, including 2 influenza A viruses and 2 influenza B viruses. All flu vaccines in the US during the 2021-2022 season are quadrivalent vaccines. Different vaccines are approved for different age groups.

Virus Type Insights

Based on virus type, the influenza vaccines market is segmented into influenza virus type A and influenza virus type B. The influenza virus type A segment is likely to hold a larger market share in 2022. The same segment is expected to record a faster CAGR during the forecast period. The market growth of the influenza virus type A segment is because it is the most common form of influenza and can infect animals, although illnesses associated with this type of flu are more common.

Technology Insights

Based on technology, the influenza vaccines market is segmented into egg-based and cell-based. The egg-based segment is likely to hold a larger market share in 2022. The same segment is expected to record a faster CAGR during the forecast period. The market growth of the egg-based segment is due to its most common method of producing flu vaccines through an egg-based manufacturing process that has been used for more than 70 years.

Route of Administration Insights

Based on route of administration, the influenza vaccines market is segmented into injection and nasal spray. The injection segment is likely to hold a larger market share in 2022. The same segment is expected to register a higher CAGR during the forecast period. The market growth of the injection segment is attributed to the fact that it is the most common method for flu vaccine administration.

Target Group Insights

Based on target group, the global influenza vaccines market is divided into infants, children, adults, and elderly people. The infants segment held larger share of the market in 2021. However, the elderly (geriatric population) segment is expected to grow at the highest growth rate during the forecast period.

International Trade Administration (ITA), Farmindustria-Bain & Company, EFPIA member associations, World Health Organization (WHO), Business Monitor International (BMI), Department of Emergency Medicine, and Indian Journal of Medical Sciences are among the primary and secondary sources referred to while preparing the report on the influenza vaccines market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the influenza vaccines market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global influenza vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Influenza Vaccines Market - By Vaccine Type
    • 1.3.2 Global Influenza Vaccines Market - By Virus Type
    • 1.3.3 Global Influenza Vaccines Market - By Technology
    • 1.3.4 Global Influenza Vaccines Market - By Route of Administration
    • 1.3.5 Global Influenza Vaccines Market - By Target Group
    • 1.3.6 Global Influenza Vaccines Market - By Geography

2. Influenza Vaccines Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Influenza Vaccines Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South and Central America PEST Analysis
  • 4.3 Experts Opinion

5. Global Influenza Vaccines Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increase in Government Support to Promote Influenza Vaccination
    • 5.1.2 Increasing Investment by Top Market Players and Governments
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Vaccine Development
  • 5.3 Market Opportunities
    • 5.3.1 Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Strong Pipeline Candidates for Influenza Vaccines
  • 5.5 Impact Analysis

6. Influenza Vaccine Market -Global Analysis

  • 6.1 Global Influenza Vaccines Market Revenue Forecasts And Analysis
  • 6.2 Global Influenza Vaccines Market, By Geography - Forecasts And Analysis
  • 6.3 Global Influenza Vaccines Market - Market Potential Analysis, By Region
  • 6.4 Company Analysis
    • 6.4.1 Market Positioning of Key Players
    • 6.4.2 Comparative Company Analysis
  • 6.5 Growth Strategy Analysis
  • 6.6 Performance of Key Players
    • 6.6.1 Sanofi
    • 6.6.2 SEQIRUS

7. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Vaccine Type

  • 7.1 Overview
  • 7.2 Global Influenza Vaccines Market, By Vaccine Type 2022 & 2028 (%)
  • 7.3 Quadrivalent Vaccines
    • 7.3.1 Overview
    • 7.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.4 Trivalent Vaccines
    • 7.4.1 Overview
    • 7.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

8. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Virus Type

  • 8.1 Overview
  • 8.2 Global Influenza Vaccines Market, By Virus Type 2022 & 2028 (%)
  • 8.3 Influenza Virus Type A
    • 8.3.1 Overview
    • 8.3.2 Influenza Virus Type A Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.4 Influenza Virus Type B
    • 8.4.1 Overview
    • 8.4.2 Influenza Virus Type B Market Revenue and Forecast to 2028 (US$ Mn)

9. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Technology

  • 9.1 Overview
  • 9.2 Global Influenza Vaccines Market, By Technology 2022 & 2028 (%)
  • 9.3 Egg-based
    • 9.3.1 Overview
    • 9.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.4 Cell-based
    • 9.4.1 Overview
    • 9.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

10. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Route of Administration

  • 10.1 Overview
  • 10.2 Global Influenza Vaccines Market, By Route of Administration 2022 & 2028 (%)
  • 10.3 Injection
    • 10.3.1 Overview
    • 10.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.4 Nasal Spray
    • 10.4.1 Overview
    • 10.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

11. Influenza Vaccines Market Analysis and Forecasts To 2028 - By Target Group

  • 11.1 Overview
  • 11.2 Global Influenza Vaccines Market, By Target Group 2022 & 2028 (%)
  • 11.3 Infants
    • 11.3.1 Overview
    • 11.3.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.4 Children
    • 11.4.1 Overview
    • 11.4.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.5 Adults
    • 11.5.1 Overview
    • 11.5.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.6 Elderly People
    • 11.6.1 Overview
    • 11.6.2 Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

12. Influenza Vaccines Market Analysis and Forecasts To 2028 - Geographical Analysis

  • 12.1 North America Influenza Vaccines Market Revenue and Forecasts To 2028
    • 12.1.1 Overview
    • 12.1.2 North America: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.1.3 North America: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
    • 12.1.4 North America: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
    • 12.1.5 North America: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
    • 12.1.6 North America: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
    • 12.1.7 North America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
    • 12.1.8 North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
      • 12.1.8.1 US: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.8.1.1 Overview
        • 12.1.8.1.2 US: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.8.1.3 US: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.1.8.1.4 US: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.1.8.1.5 US: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.1.8.1.6 US: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.1.8.1.7 US: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.1.8.2 Canada: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.8.2.1 Overview
        • 12.1.8.2.2 Canada: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.8.2.3 Canada: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.1.8.2.4 Canada: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.1.8.2.5 Canada: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.1.8.2.6 Canada: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.1.8.2.7 Canada: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.1.8.3 Mexico: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.8.3.1 Overview
        • 12.1.8.3.2 Mexico: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.1.8.3.3 Mexico: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.1.8.3.4 Mexico: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.1.8.3.5 Mexico: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.1.8.3.6 Mexico: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.1.8.3.7 Mexico: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  • 12.2 Europe: Influenza Vaccines Market
    • 12.2.1 Overview
    • 12.2.2 Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.2.3 Europe: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
    • 12.2.4 Europe: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
    • 12.2.5 Europe: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
    • 12.2.6 Europe: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
    • 12.2.7 Europe: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
    • 12.2.8 Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
      • 12.2.8.1 Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.1.1 Overview
        • 12.2.8.1.2 Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.1.3 Germany: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.2.8.1.4 Germany: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.2.8.1.5 Germany: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.2.8.1.6 Germany: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.2.8.1.7 Germany: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.2.8.2 UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.2.1 Overview
        • 12.2.8.2.2 UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.2.3 UK: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.2.8.2.4 UK: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.2.8.2.5 UK: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.2.8.2.6 UK: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.2.8.2.7 UK: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.2.8.3 France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.3.1 Overview
        • 12.2.8.3.2 France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.3.3 France: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.2.8.3.4 France: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.2.8.3.5 France: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.2.8.3.6 France: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.2.8.3.7 France: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.2.8.4 Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.4.1 Overview
        • 12.2.8.4.2 Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.4.3 Italy: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.2.8.4.4 Italy: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.2.8.4.5 Italy: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.2.8.4.6 Italy: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.2.8.4.7 Italy: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.2.8.5 Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.5.1 Overview
        • 12.2.8.5.2 Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.5.3 Spain: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.2.8.5.4 Spain: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.2.8.5.5 Spain: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.2.8.5.6 Spain: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.2.8.5.7 Spain: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.2.8.6 Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.6.1 Overview
        • 12.2.8.6.2 Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.2.8.6.3 Rest of Europe: Influenza Vaccines Market, by Vaccine Type, 2019-2028 (US$ Million)
        • 12.2.8.6.4 Rest of Europe: Influenza Vaccines Market, by Virus Type, 2019-2028 (US$ Million)
        • 12.2.8.6.5 Rest of Europe: Influenza Vaccines Market, by Technology, 2019-2028 (US$ Million)
        • 12.2.8.6.6 Rest of Europe: Influenza Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
        • 12.2.8.6.7 Rest of Europe: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  • 12.3 Asia Pacific: Influenza Vaccines Market
    • 12.3.1 Overview
    • 12.3.2 Asia Pacific Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
    • 12.3.3 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
    • 12.3.4 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
    • 12.3.5 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
    • 12.3.6 Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
    • 12.3.7 Asia Pacific: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
    • 12.3.8 Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
      • 12.3.8.1 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.1.1 Overview
        • 12.3.8.1.2 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.1.3 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
        • 12.3.8.1.4 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
        • 12.3.8.1.5 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 12.3.8.1.6 Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.3.8.1.7 Japan: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.3.8.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.2.1 Overview
        • 12.3.8.2.2 China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.2.3 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
        • 12.3.8.2.4 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
        • 12.3.8.2.5 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 12.3.8.2.6 China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.3.8.2.7 China: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.3.8.3 India Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.3.1 Overview
        • 12.3.8.3.2 India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.3.3 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
        • 12.3.8.3.4 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
        • 12.3.8.3.5 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 12.3.8.3.6 India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.3.8.3.7 India: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.3.8.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.4.1 Overview
        • 12.3.8.4.2 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.4.3 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
        • 12.3.8.4.4 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
        • 12.3.8.4.5 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 12.3.8.4.6 South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.3.8.4.7 South Korea: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.3.8.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.5.1 Overview
        • 12.3.8.5.2 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.3.8.5.3 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
        • 12.3.8.5.4 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
        • 12.3.8.5.5 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 12.3.8.5.6 Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.3.8.5.7 Australia: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.3.8.6 Rest of Asia Pacific: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.3.8.6.1 Overview
        • 12.3.8.6.2 Rest of Asia Pacific: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 12.3.8.6.3 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
        • 12.3.8.6.4 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
        • 12.3.8.6.5 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
        • 12.3.8.6.6 Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
        • 12.3.8.6.7 Rest of Asia Pacific: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  • 12.4 Middle East & Africa Influenza Vaccine Market Revenue and Forecasts To 2028
    • 12.4.1 Overview
    • 12.4.2 Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.4.3 Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    • 12.4.4 Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    • 12.4.5 Middle East & Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
    • 12.4.6 Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
    • 12.4.7 Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
    • 12.4.8 Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
      • 12.4.8.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.1.1 Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.1.2 Saudi Arabia: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.4.8.1.3 Saudi Arabia: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.4.8.1.4 Saudi Arabia Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.1.5 Saudi Arabia Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.1.6 Saudi Arabia: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.4.8.2 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.2.1 UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.2.2 UAE: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.4.8.2.3 UAE: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.4.8.2.4 UAE Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.2.5 UAE Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.2.6 UAE: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.4.8.3 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.3.1 South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.3.2 South Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.4.8.3.3 South Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.4.8.3.4 South Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.3.5 South Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.3.6 South Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.4.8.4 Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.4.1 Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.4.8.4.2 Rest of Middle East & Africa: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.4.8.4.3 Rest of Middle East & Africa: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.4.8.4.4 Rest of Middle East & Africa: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
        • 12.4.8.4.5 Rest of Middle East & Africa: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
        • 12.4.8.4.6 Rest of Middle East & Africa: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
  • 12.5 South and Central America Influenza Vaccine Market Revenue and Forecasts To 2028
    • 12.5.1 Overview
    • 12.5.2 South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
    • 12.5.3 South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
    • 12.5.4 South and Central America: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
    • 12.5.5 South and Central America: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
    • 12.5.6 South and Central America: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
    • 12.5.7 South and Central America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
    • 12.5.8 South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
      • 12.5.8.1 Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.5.8.1.1 Overview
        • 12.5.8.1.2 Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.5.8.1.3 Brazil: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.5.8.1.4 Brazil: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.5.8.1.5 Brazil: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
        • 12.5.8.1.6 Brazil: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
        • 12.5.8.1.7 Brazil: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.5.8.2 Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.5.8.2.1 Overview
        • 12.5.8.2.2 Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.5.8.2.3 Argentina: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.5.8.2.4 Argentina: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.5.8.2.5 Argentina: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
        • 12.5.8.2.6 Argentina: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
        • 12.5.8.2.7 Argentina: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)
      • 12.5.8.3 Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.5.8.3.1 Overview
        • 12.5.8.3.2 Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
        • 12.5.8.3.3 Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type, 2019-2028 (USD Million)
        • 12.5.8.3.4 Rest of South and Central America: Influenza Vaccine Market, by Virus Type, 2019-2028 (USD Million)
        • 12.5.8.3.5 Rest of South and Central America: Influenza Vaccine Market, by Technology, 2019-2028 (USD Million)
        • 12.5.8.3.6 Rest of South and Central America: Influenza Vaccine Market, by Route of Administration, 2019-2028 (USD Million)
        • 12.5.8.3.7 Rest of South and Central America: Influenza Vaccines Market, by Target Group, 2019-2028 (US$ Million)

13. Impact of COVID-19 Pandemic on Global Influenza Vaccines Market

  • 13.1 North America: Impact Assessment of COVID-19 Pandemic
  • 13.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 13.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 13.5 South and Central America: Impact Assessment of COVID-19 Pandemic

14. Influenza Vaccine Market -Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies in the Influenza Vaccine Market, 2021-2028
  • 14.3 Inorganic Growth Strategies
    • 14.3.1 Overview
  • 14.4 Organic Growth Strategies
    • 14.4.1 Overview

15. Company Profiles

  • 15.1 Moderna, Inc.
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 SEQIRUS
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Sanofi
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 GlaxoSmithKline plc.
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 Hualan Biological Engineering Inc.
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 Emergent BioSolutions Inc.
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 Mitsubishi Chemical Group Corporation
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 Serum Institute of India Pvt. Ltd
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 MYLAN N.V.
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 AstraZeneca
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms

List Of Tables

  • Table 1. North America Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 4. North America Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 5. North America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 6. US Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. US Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. US Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. US Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 11. Canada Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Canada Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Canada Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Canada Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Canada Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 16. Mexico Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Mexico Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Mexico Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Mexico Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Mexico Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 21. Europe Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. Europe: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. Europe Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. Europe Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Europe Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 26. Germany Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Germany: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Germany Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Germany Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Germany Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 31. UK Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. UK: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. UK Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. UK Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 35. UK Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 36. France Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. France: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. France Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. France Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. France Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 41. Italy Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Italy: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Italy Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. Italy Influenza Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. Italy Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 46. Spain Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. Spain: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. Spain Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Spain Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Spain Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 51. Rest of Europe Influenza Vaccines Market, by Vaccine Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Rest of Europe: Influenza Vaccines Market, by Virus Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Europe Influenza Vaccines Market, by Technology - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Europe Influenza Vaccines Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Rest of Europe Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 56. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million).
  • Table 57. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 58. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 59. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Segment-5 (US$ Million)
  • Table 60. Asia Pacific Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 61. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
  • Table 62. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 63. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 64. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 65. Japan Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 66. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
  • Table 67. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 68. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 69. China: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 70. China Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 71. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
  • Table 72. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 73. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 74. India: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 75. India Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 76. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
  • Table 77. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 78. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 79. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 80. South Korea Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 81. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
  • Table 82. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 83. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 84. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 85. Australia Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 86. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Vaccine Type (US$ Million)
  • Table 87. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Virus Type (US$ Million)
  • Table 88. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Technology (US$ Million)
  • Table 89. Rest of Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)
  • Table 90. Rest of Asia Pacific Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 91. Middle East & Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 92. Middle East & Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 93. Middle East & Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 94. Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 95. Middle East & Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 96. Saudi Arabia Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 97. Saudi Arabia Influenza Vaccine Market, by Virus Type- Revenue and Forecast to 2028 (USD Million)
  • Table 98. Saudi Arabia Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 99. Saudi Arabia Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 100. Saudi Arabia Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 101. UAE Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 102. UAE Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 103. UAE Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 104. UAE Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 105. UAE Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 106. South Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 107. South Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 108. South Africa Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 109. South Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 110. South Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 111. Rest of Middle East & Africa Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 112. Rest of Middle East & Africa Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 113. Rest of Middle East & Africa Influenza Vaccine Market, by Technology- Revenue and Forecast to 2028 (USD Million)
  • Table 114. Rest of Middle East & Africa Influenza Vaccine Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 115. Rest of Middle East & Africa Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 116. South and Central America: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 117. South and Central America: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 118. South and Central America: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 119. South and Central America: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 120. South and Central America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 121. Brazil: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 122. Brazil: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 123. Brazil: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 124. Brazil: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 125. Brazil Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 126. Argentina: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 127. Argentina: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 128. Argentina: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 129. Argentina: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 130. Argentina Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 131. Rest of South and Central America: Influenza Vaccine Market, by Vaccine Type - Revenue and Forecast to 2028 (USD Million)
  • Table 132. Rest of South and Central America: Influenza Vaccine Market, by Virus Type - Revenue and Forecast to 2028 (USD Million)
  • Table 133. Rest of South and Central America: Influenza Vaccine Market, by Technology - Revenue and Forecast to 2028 (USD Million)
  • Table 134. Rest of South and Central America: Influenza Vaccine Market, by Route of Administration- Revenue and Forecast to 2028 (USD Million)
  • Table 135. Rest of South and Central America Influenza Vaccines Market, by Target Group- Revenue and Forecast to 2028 (USD Million)
  • Table 136. Recent Inorganic Growth Strategies in the Influenza Vaccine Market
  • Table 137. Recent Organic Growth Strategies in the Influenza Vaccine Market
  • Table 138. Glossary of Terms, Influenza Vaccines Market

List Of Figures

  • Figure 1. Influenza Vaccines Market Segmentation
  • Figure 2. Influenza Vaccines Market Segmentation, by Region
  • Figure 3. Global Influenza Vaccines Market Overview
  • Figure 4. Quadrivalent Vaccines Segment Held Largest Share of Product Segment in Influenza Vaccines Market
  • Figure 5. Asia Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Influenza Vaccines Market, By Geography (USD Million)
  • Figure 7. Global Influenza Vaccines Market- Leading Country Markets (USD Million)
  • Figure 8. Global Influenza Vaccines Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South and Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Global Influenza Vaccines Market - Revenue Forecasts and Analysis - 2020- 2028
  • Figure 16. Global Influenza Vaccines Market - By Geography Forecasts and Analysis - 2022- 2028
  • Figure 17. Global Influenza Vaccines Market - Market Potential Analysis, By Region
  • Figure 18. Market Positioning of Key Players In Global Influenza Vaccines Market
  • Figure 19. Global Influenza Vaccines Market - Comparative Company Analysis
  • Figure 20. Global Influenza Vaccines Market - Growth Strategy Analysis
  • Figure 21. Global Influenza Vaccines Market, by Vaccine Type 2022 & 2028 (%)
  • Figure 22. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 23. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 24. Global Influenza Vaccines Market, by Virus Type 2022 & 2028 (%)
  • Figure 25. Powder Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 26. Tablets Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 27. Global Influenza Vaccines Market, by Technology 2022 & 2028 (%)
  • Figure 28. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 29. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 30. Global Influenza Vaccines Market, by Route of Administration 2022 & 2028 (%)
  • Figure 31. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 32. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 33. Global Influenza Vaccines Market, by Target Group 2022 & 2028 (%)
  • Figure 34. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 35. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 36. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 37. Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 38. North America: Influenza Vaccines Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 39. North America Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. North America: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
  • Figure 41. US: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Canada: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Mexico: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Europe: Influenza Vaccines Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 45. Europe Influenza Vaccines Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Europe: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
  • Figure 47. Germany: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. UK: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. France: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. Italy: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. Spain: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Rest of Europe: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Asia Pacific Influenza Vaccines Market Overview, by Country (2022)
  • Figure 54. Asia Pacific: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 55. Asia Pacific: Influenza Vaccines Market, by Country, 2022 & 2028 (%)
  • Figure 56. Japan: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 57. China: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 58. India: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 59. South Korea: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 60. Australia: Influenza Vaccines Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 61. Rest of Asia Pacific: Influenza Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Middle East & Africa: Influenza Vaccine Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 63. Middle East & Africa Influenza Vaccine Market Revenue and Forecast to 2028 (USD Million)
  • Figure 64. Middle East & Africa: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
  • Figure 65. Saudi Arabia: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 66. UAE: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 67. South Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 68. Rest of Middle East & Africa: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 69. South and Central America: Influenza Vaccine Market, by Key Country - Revenue (2022) (USD Million)
  • Figure 70. South and Central America Influenza Vaccine Market Revenue and Forecast to 2028 (USD Million)
  • Figure 71. South and Central America: Influenza Vaccine Market, by Country, 2022 & 2028 (%)
  • Figure 72. Brazil: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 73. Argentina: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 74. Rest of South and Central America: Influenza Vaccine Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 75. Impact of COVID-19 Pandemic on North America Countries
  • Figure 76. Impact of COVID-19 Pandemic on European Countries
  • Figure 77. Impact of COVID-19 Pandemic on Asia Pacific Countries
  • Figure 78. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 79. Impact of COVID-19 Pandemic in South and Central American Countries
  • Figure 80. Growth Strategies in the Influenza Vaccine Market, 2021-2028